Abstract
Protection facilitated by the widespread use of mineral oil adjuvanted injection vaccines in salmonid fish comes with adverse effects of varying severity. In this study, we characterized the immunological profiles of two alternative vaccine formulations, both with proven efficacy and an improved safety profile in rainbow trout. Experimental injection vaccines were prepared on an identical whole-cell Aeromonas salmonicida bacterin platform and were formulated with CpG oligodeoxynucleotides, a liposomal (CAF01) or a benchmark mineral oil adjuvant, respectively. A naïve group, as well as bacterin and saline-injected groups were also included. Following administration, antigen-specific serum antibody titers, the tissue distribution of immune cell markers, and the expression of immune-relevant genes following the in vitro antigenic restimulation of anterior kidney leukocytes was investigated. Immunohistochemical staining suggested prolonged antigen presentation for the particulate formulations and increased mucosal presence of antigen-presenting cells in all immunized fish. Unlike the other immunized groups, the CAF01 group only displayed a transient elevation in specific antibody titers and immunohistochemical observations, and the transcription data suggest an increased role of cell-mediated immunity for this group. Finally, the transcription profile of the CpG formulation approached that of a TH1 profile. When compared to the benchmark formulation, CAF01 and CpG adjuvants induce slight, but distinct differences in the resulting protective immune responses. This is important, as it allows a broader immunological approach for the future development of safer vaccines.
Highlights
Successful prophylactic strategies in the form of vaccination programs represent a fundamental factor in the success of modern aquaculture
Serving to both minimize the use of antibiotics, as well as to facilitate increased production [1], vaccines are administered to large numbers of farmed fish, including salmonids such as Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss), on an annual basis
While vaccination against some bacterial pathogens has been successfully performed by bath exposure [2,3,4,5], others require the injection of adjuvanted vaccine formulations in order to induce a satisfactory level of protection [6]
Summary
Successful prophylactic strategies in the form of vaccination programs represent a fundamental factor in the success of modern aquaculture Serving to both minimize the use of antibiotics, as well as to facilitate increased production [1], vaccines are administered to large numbers of farmed fish, including salmonids such as Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss), on an annual basis. A number of studies, have demonstrated adverse effects of varying severity following the intraperitoneal injection of mineral oil adjuvanted vaccines in salmon and rainbow trout [11,12,13,14,15,16,17,18,19] These findings warrant a continued effort to identify potential alternative vaccine formulations that can offer a similar or better protection, while at the same time reducing or preferably eliminating adverse effects
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
